Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 8146 AL 8160

The roles of biomarkers in Alzheimer's disease clinical trials

Cummings J, Sharma S, DeAndrea G, Osse AL, Ortiz A.

Neurotherapeutics. 2026 Jan;23(1):e00811. doi: 10.1016/j.neurot.2025.e00811. Epub 2025 Dec 24.

The impact of real-world evidence in implementing and optimizing Alzheimer's disease care

Hampel H, Li G, Mielke MM, Galvin JE, Kivipelto M, Santarnecchi E, Babiloni C, Devanarayan V, Tkatch R, Hu Y, Kurzman R, Cho M, Vandercappellen J, Nakamura Y, Bell J, Mattke S, Toschi N.

Med. 2025 May 9;6(5):100695. doi: 10.1016/j.medj.2025.100695.

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease

Yim S, Gu Y, Kang H, Shin D, Jang H, Yoo H, Zetterberg H, Blennow K, Gonzalez-Ortiz F, Ashton NJ, Weiner MW, Day TA, Lee EH, Na DL, Kim HJ, Kang SH, Kim KW, Kim YJ, Kim Y, Kim J, Chun MY, Jung NY, Cho SH, Kim JP, Yun J, Seo SW; K-ROAD study groups.

Clin Nucl Med. 2025 Dec 1;50(12):1120-1129. doi: 10.1097/RLU.0000000000006088. Epub 2025 Sep 1.

Tracking electrophysiological signatures of Alzheimer's disease: a systematic review of multimodal studies

Sohrabpour A, Sarovic D, Zetterberg H, Hämäläinen MS, Baillet S, Khan S.

Alzheimers Dement. 2025 Nov;21(11):e70835. doi: 10.1002/alz.70835.

Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia-specific perspectives

Iwatsubo T, Sperling RA, Algeciras-Schimnich A, Arai H, Barron AM, Benzinger TLS, Carrillo MC, Chen C, Choi SH, Fontana IC, Graff-Radford J, Grill JD, Heidebrink J, Hu CJ, Ihara R, Ikeuchi T, Iwata A, Ip FCF, Fitri FI, Jack CR Jr, Jeong JH, Jia J, Kandiah N, Kim S, Kowa H, La Joie R, Niimi Y, Noritake R, Okonkwo OC, Palmqvist S, Rafii MS, Raman R, Shen Y, Simuni T, Snyder HM, Sriwannopas O, Stoeckel LE, van der Flier WM, Wang H, Wilcock DM, Zetterberg H, Zhou J, Mahinrad S, Sexton CE.

Alzheimers Dement. 2025 Aug;21(8):e70536. doi: 10.1002/alz.70536.

Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease

Garbarino VR, Palavicini JP, Melendez J, Barthelemy NR, He Y, Kautz TF, Lopez-Cruzan M, Mathews JJ, Xu P, Zhang B, Saliba A, Ragi N, Sharma K, Mason D, Johnson S, Hendrix S, Craft S, Petersen RC, Espindola-Netto JM, Xue A, Tchkonia T, Kirkland JL, Salardini A, Musi N, Bateman RJ, Gonzales MM, Orr ME.

Neurotherapeutics. 2025 Jul;22(4):e00591. doi: 10.1016/j.neurot.2025.e00591. Epub 2025 Apr 23.

Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications

Akash A, Ahamed M, Porel P, Aran KR.

Brain Res. 2025 Nov 15;1867:149949. doi: 10.1016/j.brainres.2025.149949. Epub 2025 Sep 19.

Analysis and interpretation of inflammatory fluid markers in Alzheimer's disease: a roadmap for standardization

Bettcher BM, de Oliveira FF, Willette AA, Michalowska MM, Machado LS, Rajbanshi B, Borelli WV, Tansey MG, Rocha A, Suryadevara V, Hu WT.

J Neuroinflammation. 2025 Apr 15;22(1):105. doi: 10.1186/s12974-025-03432-4.

Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring

Petersen ME, Flores-Aguilar L, Head E, Montoliu-Gaya L, Strydom A, Pape SE, Fortea J, Ashton NJ, Udeh-Momoh C, O'Bryant SE, German D, Despa F, Mapstone M, Zetterberg H.

Alzheimers Dement. 2025 Jan;21(1):e14364. doi: 10.1002/alz.14364. Epub 2024 Nov 13.

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease

Qiu Y, Jacobs DM, Messer K, Salmon DP, Wellington CL, Stukas S, Revta C, Brewer JB, Léger GC, Askew B, Donahue L, Kaplita S, Coric V, Qureshi IA, Feldman HH; Alzheimer’s Disease Cooperative Study T2 Protect AD Study Group.

Alzheimers Res Ther. 2025 May 2;17(1):97. doi: 10.1186/s13195-025-01745-3.

Digital twins and non-invasive recordings enable early diagnosis of Alzheimer's disease

Amato LG, Lassi M, Vergani AA, Carpaneto J, Mazzeo S, Moschini V, Burali R, Salvestrini G, Fabbiani C, Giacomucci G, Galdo G, Morinelli C, Emiliani F, Scarpino M, Padiglioni S, Nacmias B, Sorbi S, Grippo A, Bessi V, Mazzoni A.

Alzheimers Res Ther. 2025 May 31;17(1):125. doi: 10.1186/s13195-025-01765-z.

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Ahmadi S, Khaledi S, Ahmadi K, Hassanzadeh K.

CNS Neurosci Ther. 2025 Dec;31(12):e70688. doi: 10.1002/cns.70688.

Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

McCullough A, Chen CD, Gordon BA, Joseph-Mathurin N, Jack CR Jr, Koeppe R, Hornbeck R, Koudelis D, McKay NS, Hobbs DA, Flores S, Keefe SJ, Aggarwal NT, Allegri RF, Berman SB, Bird T, Black SE, Brooks WS, Chhatwal JP, Day GS, Farlow MR, Fox NC, Gauthier S, Honig LS, Hsiung GY, Jucker M, Levin J, Masellis M, Masters C, Mendez PC, Ringman JM, Snider BJ, Salloway S, Schofield PR, Shimada H, Suzuki K, van Dyck CH, Klein G, Clifford DB, Cruchaga C, Hassenstab J, Li Y, McDade E, Mills S, Morris JC, Perrin RJ, Supnet-Bell C, Wang G, Xiong C, Bateman RJ, Benzinger TLS; DIAN‐TU Study Team.

Alzheimers Dement. 2025 Jul;21(7):e70347. doi: 10.1002/alz.70347.

Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging

Banihashemi MA, Krance SH, Ji PX, Koo M, Ottoy J, Swartz RH, Kertes PJ, Hudson C, Goubran M, Black SE.

Alzheimers Dement. 2025 Nov;21(11):e70884. doi: 10.1002/alz.70884.

Recent advances in neuroimaging of Alzheimer's disease and related dementias

Ottoy J, Owsicki N, Bilgel M, Binette AP, Salvadó G, Kang MS, Cash DM, Ewers M, La Joie R, Wisse LEM, Goubran M, Betthauser T.

Alzheimers Dement. 2025 Sep;21(9):e70648. doi: 10.1002/alz.70648.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias